arXiv:2605.25581v1 Announce Type: new Abstract: Single-cell perturbation prediction aims to infer how cells respond to unseen interventions and to achieve out-of-distribution (OOD) generalization, providing a computational route to understanding how perturbations reshape cellular programs over time. Existing machine learning methods have made important progress, but typically capture only one side of the response. Latent causal approaches seek mechanisms that support generalization and interpretation, yet often treat perturbation effects as static outcomes. Temporal models describe how gene ex
Advances in AI, particularly in generative models and causal inference, are enabling new approaches to understanding complex biological systems at a cellular level.
This research provides a computational pathway to predict cellular responses to therapeutic interventions, accelerating drug discovery and personalized medicine.
The ability to predict cellular responses more accurately out-of-distribution shifts how drug discovery and synthetic biology interventions can be designed and tested.
- · Pharmaceutical companies
- · Biotech firms
- · AI/ML researchers in biology
- · Personalized medicine
- · Traditional drug screening methods
- · Trial-and-error drug development
- · Disease areas with high research costs
More efficient and targeted drug discovery processes will emerge, leading to novel therapies.
Reduced R&D costs in drug development may democratize access to advanced therapeutics or shift investment towards neglected diseases.
The deep understanding of cellular programs could enable advanced bio-engineering for synthetic organisms or disease prevention at a fundamental level.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at arXiv cs.LG